RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2017

Oct 4, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2017-10-04

Reporting Person: MCGIRR DAVID W J (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (Right to Buy)	$4.59	2025-11-16	Common Stock (65431)		Direct
Employee Stock Option (Right to Buy)	$6.05	2027-02-07	Common Stock (21810)		Direct

Footnotes

F1: The stock options were granted on November 17, 2015 and vest and become exercisable in three equal annual installments measured from November 11, 2015.

F2: The stock options were granted on February 8, 2017 and vest and become exercisable in three equal annual installments measured from January 6, 2017.